Michail S Lionakis Selected Research

Monoclonal Antibodies

1/2022	Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
1/2021	SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michail S Lionakis Research Topics

Disease

43	Infections 04/2024 - 11/2003
24	COVID-19 04/2024 - 01/2020
23	Mycoses (Diseases, Fungus) 03/2024 - 11/2003
15	Neoplasms (Cancer) 05/2024 - 01/2004
14	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2023 - 08/2016
13	Candidiasis (Moniliasis) 01/2022 - 01/2012
12	Pneumonia (Pneumonitis) 10/2023 - 01/2019
11	Aspergillosis 05/2024 - 07/2004
9	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2018
7	Inflammation (Inflammations) 01/2024 - 06/2015
6	Invasive Fungal Infections 01/2022 - 11/2003
5	autosomal recessive Candidiasis familial chronic mucocutaneous 01/2024 - 12/2015
5	type 1 Autoimmune polyendocrinopathy syndrome 01/2023 - 12/2019
5	Systemic candidiasis 01/2020 - 08/2014
4	Invasive Candidiasis 12/2023 - 01/2012
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 06/2015
4	Atherosclerosis 12/2021 - 08/2011
4	Hematologic Neoplasms (Hematological Malignancy) 12/2019 - 06/2015
4	Neutropenia 01/2019 - 01/2012
3	Opportunistic Infections (Opportunistic Infection) 03/2024 - 01/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2023 - 01/2022
3	Chronic Granulomatous Disease 12/2020 - 04/2016
3	Primary Immunodeficiency Diseases 12/2020 - 01/2016
3	Invasive Pulmonary Aspergillosis 01/2020 - 11/2005
3	Atherosclerotic Plaque (Atheroma) 06/2015 - 08/2011
2	Coinfection 04/2024 - 01/2022
2	Thymoma (Thymic Carcinoma) 03/2024 - 11/2021
2	Cryptococcosis 02/2024 - 01/2023
2	Kidney Diseases (Kidney Disease) 08/2023 - 01/2020
2	Candidemia 01/2023 - 01/2019
2	Hepatitis 01/2023 - 01/2021
2	Dysbiosis 12/2022 - 01/2022
2	COVID-19 related pediatric multisystem inflammatory disease 10/2022 - 03/2022
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2022 - 03/2022
2	Hypoparathyroidism 01/2021 - 01/2021
2	Nephrocalcinosis 01/2021 - 01/2021
2	Bacterial Infections (Bacterial Infection) 12/2020 - 10/2016

Drug/Important Bio-Agent (IBA)

22	AutoantibodiesIBA 03/2024 - 08/2016
10	InterferonsIBA 04/2024 - 12/2019
10	Interleukin-17 (Interleukin 17)IBA 01/2023 - 03/2015
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
8	CytokinesIBA 01/2023 - 06/2015
7	Interferon Type IIBA 04/2024 - 06/2020
7	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2019
7	Chemokine ReceptorsIBA 01/2017 - 08/2011
7	LigandsIBA 01/2016 - 11/2005
6	Messenger RNA (mRNA)IBA 12/2023 - 01/2017
6	Complement System Proteins (Complement)IBA 01/2023 - 06/2020
6	Voriconazole (Vfend)FDA LinkGeneric 07/2005 - 07/2004
5	Agammaglobulinaemia Tyrosine KinaseIBA 05/2024 - 12/2017
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 12/2020
5	AntibodiesIBA 01/2023 - 09/2015
5	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022 - 07/2004
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2015
4	TriazolesIBA 08/2023 - 11/2003
4	ibrutinibIBA 01/2023 - 12/2017
4	AntigensIBA 10/2022 - 12/2019
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
4	Antifungal AgentsIBA 01/2018 - 07/2005
3	Interleukin-23 (Interleukin 23)IBA 03/2024 - 03/2015
3	Interleukin-12 (IL 12)IBA 03/2024 - 10/2016
3	EpitopesIBA 12/2023 - 03/2021
3	mRNA VaccinesIBA 12/2023 - 11/2021
3	Immunoglobulin G (IgG)IBA 10/2023 - 10/2020
3	posaconazole FDA Link 08/2023 - 02/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 04/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2019
3	AutoantigensIBA 01/2023 - 03/2022
3	GlucansIBA 11/2022 - 01/2019
3	AzolesIBA 01/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
3	C-Type Lectins (C-Type Lectin)IBA 01/2019 - 12/2015
3	Immunologic Factors (Immunomodulators)IBA 09/2018 - 08/2014
3	Fluconazole (Zonal)FDA LinkGeneric 01/2018 - 11/2003
3	Apolipoproteins E (ApoE)IBA 06/2015 - 08/2011
3	ApolipoproteinsIBA 06/2015 - 08/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2024 - 01/2022
2	ProteomeIBA 12/2023 - 01/2023
2	VaccinesIBA 10/2023 - 11/2021
2	NF-kappa B (NF-kB)IBA 01/2023 - 06/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 01/2018
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 10/2022 - 03/2022
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Pattern Recognition ReceptorsIBA 01/2022 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	EphrinsIBA 01/2022 - 01/2019
2	CholesterolIBA 12/2021 - 06/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 03/2021 - 01/2021
2	InflammasomesIBA 01/2021 - 10/2018
2	Vitamin D FDA LinkGeneric 01/2021 - 07/2020
2	CalciumIBA 01/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 12/2019
2	STAT1 Transcription FactorIBA 01/2021 - 01/2017
2	NADP (NADPH)IBA 12/2020 - 04/2016

Therapy/Procedure

27	Therapeutics 01/2024 - 11/2003
5	Transplantation 11/2022 - 10/2016
3	Artificial Respiration (Mechanical Ventilation) 10/2023 - 01/2020
3	Immunotherapy 01/2023 - 01/2022
3	Drug Therapy (Chemotherapy) 01/2023 - 10/2016
2	Organ Transplantation 10/2023 - 06/2015